Evelyn M Jiagge1,2,3, Peter J Ulintz4,5, Shukmei Wong6, Sean P McDermott4, Sabrina I Fossi7,4, Tahra K Suhan5,8, Mark J Hoenerhoff9, Jessica M Bensenhaver7, Barbara Salem10, Michele Dziubinski5, Joseph K Oppong11, Francis Aitpillah11, Kyei Ishmael11, Ernest Osei-Bonsu11, Ernest Adjei11, Awuah Baffour11, Jessica Aldrich6, Ahmet Kurdoglu6, Kurt Fernando7, David W Craig12, Jeff M Trent6, Jun Li5, Dhananjay Chitale7, Lisa A Newman13, John D Carpten12, Max S Wicha4,5, Sofia D Merajver14,15. 1. Henry Ford Cancer Institute/Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202, USA. ejiagge1@hfhs.org. 2. Department of Internal Medicine, Michigan Medicine, University of Michigan, 1500 East Medical Center Drive, RCC 7314, Ann Arbor, MI, 48105, USA. ejiagge1@hfhs.org. 3. Rogel Cancer Center, University of Michigan, Ann Arbor, MI, 48105, USA. ejiagge1@hfhs.org. 4. Department of Internal Medicine, Michigan Medicine, University of Michigan, 1500 East Medical Center Drive, RCC 7314, Ann Arbor, MI, 48105, USA. 5. Rogel Cancer Center, University of Michigan, Ann Arbor, MI, 48105, USA. 6. The Translational Genomics Research Institute, Phoenix, AZ, USA. 7. Henry Ford Cancer Institute/Henry Ford Health System, 2799 W Grand Blvd, Detroit, MI, 48202, USA. 8. Department of Urology, Michigan Medicine, University of Michigan, Ann Arbor, USA. 9. Unit for Laboratory Animal Medicine, University of Michigan, Ann Arbor, USA. 10. Michigan Institute for Clinical & Health Research, Ann Arbor, USA. 11. Komfo Anokye Teaching Hospital, Kumasi, Ghana. 12. Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. 13. New York-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, New York, NY, USA. 14. Department of Internal Medicine, Michigan Medicine, University of Michigan, 1500 East Medical Center Drive, RCC 7314, Ann Arbor, MI, 48105, USA. smerajve@med.umich.edu. 15. Rogel Cancer Center, University of Michigan, Ann Arbor, MI, 48105, USA. smerajve@med.umich.edu.
Abstract
PURPOSE: Triple-negative breast cancer (TNBC) is an aggressive subtype most prevalent among women of Western Sub-Saharan African ancestry. It accounts for 15-25% of African American (AA) breast cancers (BC) and up to 80% of Ghanaian breast cancers, thus contributing to outcome disparities in BC for black women. The aggressive biology of TNBC has been shown to be regulated partially by breast cancer stem cells (BCSC) which mediate tumor recurrence and metastasis and are more abundant in African breast tumors. METHODS: We studied the biological differences between TNBC in women with African ancestry and those of Caucasian women by comparing the gene expression of the BCSC. From low-passage patient derived xenografts (PDX) from Ghanaian (GH), AA, and Caucasian American (CA) TNBCs, we sorted for and sequenced the stem cell populations and analyzed for differential gene enrichment. RESULTS: In our cohort of TNBC tumors, we observed that the ALDH expressing stem cells display distinct ethnic specific gene expression patterns, with the largest difference existing between the GH and AA ALDH+ cells. Furthermore, the tumors from the women of African ancestry [GH/AA] had ALDH stem cell (SC) enrichment for expression of immune related genes and processes. Among the significantly upregulated genes were CD274 (PD-L1), CXCR9, CXCR10 and IFI27, which could serve as potential drug targets. CONCLUSIONS: Further exploration of the role of immune regulated genes and biological processes in BCSC may offer insight into developing novel approaches to treating TNBC to help ameliorate survival disparities in women with African ancestry.
PURPOSE: Triple-negative breast cancer (TNBC) is an aggressive subtype most prevalent among women of Western Sub-Saharan African ancestry. It accounts for 15-25% of African American (AA) breast cancers (BC) and up to 80% of Ghanaian breast cancers, thus contributing to outcome disparities in BC for black women. The aggressive biology of TNBC has been shown to be regulated partially by breast cancer stem cells (BCSC) which mediate tumor recurrence and metastasis and are more abundant in African breast tumors. METHODS: We studied the biological differences between TNBC in women with African ancestry and those of Caucasian women by comparing the gene expression of the BCSC. From low-passage patient derived xenografts (PDX) from Ghanaian (GH), AA, and Caucasian American (CA) TNBCs, we sorted for and sequenced the stem cell populations and analyzed for differential gene enrichment. RESULTS: In our cohort of TNBC tumors, we observed that the ALDH expressing stem cells display distinct ethnic specific gene expression patterns, with the largest difference existing between the GH and AA ALDH+ cells. Furthermore, the tumors from the women of African ancestry [GH/AA] had ALDH stem cell (SC) enrichment for expression of immune related genes and processes. Among the significantly upregulated genes were CD274 (PD-L1), CXCR9, CXCR10 and IFI27, which could serve as potential drug targets. CONCLUSIONS: Further exploration of the role of immune regulated genes and biological processes in BCSC may offer insight into developing novel approaches to treating TNBC to help ameliorate survival disparities in women with African ancestry.
Entities:
Keywords:
African ancestry; Breast cancer stem cells; Gene expression; Triple-negative breast cancer
Authors: Lacey E Dobrolecki; Susie D Airhart; Denis G Alferez; Samuel Aparicio; Fariba Behbod; Mohamed Bentires-Alj; Cathrin Brisken; Carol J Bult; Shirong Cai; Robert B Clarke; Heidi Dowst; Matthew J Ellis; Eva Gonzalez-Suarez; Richard D Iggo; Peter Kabos; Shunqiang Li; Geoffrey J Lindeman; Elisabetta Marangoni; Aaron McCoy; Funda Meric-Bernstam; Helen Piwnica-Worms; Marie-France Poupon; Jorge Reis-Filho; Carol A Sartorius; Valentina Scabia; George Sflomos; Yizheng Tu; François Vaillant; Jane E Visvader; Alana Welm; Max S Wicha; Michael T Lewis Journal: Cancer Metastasis Rev Date: 2016-12 Impact factor: 9.264
Authors: Evelyn Jiagge; Aisha Souleiman Jibril; Melissa Davis; Carlos Murga-Zamalloa; Celina G Kleer; Kofi Gyan; George Divine; Mark Hoenerhoff; Jessica Bensenhave; Baffour Awuah; Joseph Oppong; Ernest Adjei; Barbara Salem; Kathy Toy; Sofia Merajver; Max Wicha; Lisa Newman Journal: J Glob Oncol Date: 2018-10